Satisfaction with inpatient treatment for first-episode psychosis among different ethnic groups: A report from the UK ÆSOP study

2010 ◽  
Vol 58 (1) ◽  
pp. 98-105 ◽  
Author(s):  
Jane Boydell ◽  
Craig Morgan ◽  
Rina Dutta ◽  
Barry Jones ◽  
Fana Alemseged ◽  
...  
2013 ◽  
Vol 27 (4) ◽  
pp. 366-373 ◽  
Author(s):  
Majid M Saleem ◽  
Michael K Harte ◽  
Kay M Marshall ◽  
Andy Scally ◽  
Anita Brewin ◽  
...  

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
M. Di Forti

Epidemiological studies have reported that the increased risk of developing psychosis in cannabis users is dose related. In addition, experimental research has shown that the active constituent of cannabis responsible for its psychotogenic effect is Delta-9-Tetrahydrocannabinol (THC) (Murray et al, 2007). Recent evidence has suggested an increased in potency (% TCH) in the cannabis seized in the UK (Potter et al, 2007). We predicted that first episode psychosis patients are more likely to use higher potency cannabis and more frequently than controls.We collected information concerning socio-demographic, clinical characteristics and cannabis use (age at first use, frequency, length of use, type of cannabis used) from a sample of 191 first-episode psychosis patients and 120 matched healthy volunteers. Cases were more likely to be regular users (p=0.05), to be current users (p=0.04) and to have smoked cannabis for longer (p=0.01). Among cannabis users, 86.8% of 1st Episode Psychosis Patients preferentially used Skunk/Sinsemilla compared to 27.7% of Controls. Only 13.2 % of 1st Episode psychosis Patients chose to use Resin/Hash compared to 76.3% of controls (OR*= 7.4 95% CI 3.4- 17.2, Adjusted for age, gender, ethnicity, level of Education and employment status).The concentration of TCH in these in South East London, ranges between 8.5 and 14 % (Potter et al, 2007). Controls (47%) were more likely to use Hash (Resin) whose average TCH concentration is 3.4% (Potter et al, 2007).Patients with first episode psychosis have smoked higher potency cannabis, for longer and with greater frequency, than healthy controls.


2012 ◽  
Vol 136 ◽  
pp. S221
Author(s):  
Adanna N. Onvejiaka ◽  
Helen Fisher ◽  
Charlotte E. Gayer-Anderson ◽  
Anisa Kurti ◽  
Susana Borges ◽  
...  

2019 ◽  
Vol 29 (4) ◽  
pp. 609-616
Author(s):  
Karen J. Coleman ◽  
Bobbi Jo Yarborough ◽  
Anne Beck ◽  
Frances L. Lynch ◽  
Christine Stewart ◽  
...  

Objective: To compare patterns of health care utilization associated with first presen­tation of psychosis among different racial and ethnic groups of patients.Design: The study was a retrospective observational design.Settings: The study was conducted in five health care systems in the western United States. All sites were also part of the Nation­al Institute of Mental Health-funded Mental Health Research Network (MHRN).Participants: Patients (n = 852) were aged 15 – 59 years (average 26.9 ± 12.2 years), 45% women, and primarily non-Hispanic White (53%), with 16% Hispanic, 10% non-Hispanic Black, 6% Asian, 1% Native Hawaiian/Pacific Islander, 1% Native Ameri­can/ Alaskan Native, and 12% unknown race/ethnicity.Methods: Data abstracted from electronic medical records and insurance claims data were organized into a research virtual data warehouse (VDW) and used for analysis.Main Outcome Measures: Variables exam­ined were patterns of health care utilization, type of comorbid mental health condition, and type of treatment received in the three years before first presentation of psychosis.Results: Compared with non-Hispanic Whites, Asian patients (16% vs 34%; P=.007) and non-Hispanic Black patients (20% vs 34%; P=.009) were less likely to have a visit with specialty mental health care before their first presentation of psychosis.Conclusions: Early detection of first episode psychosis should start with wider screening for symptoms outside of any indicators for mental health conditions for non-Hispanic Black and Asian patients. Ethn Dis. 2019;29(4):609-616; doi:10.18865/ ed.29.4.609


Author(s):  
Steven Marwaha ◽  
Danielle Hett ◽  
Sonia Johnson ◽  
David Fowler ◽  
Joanne Hodgekins ◽  
...  

2000 ◽  
Vol 41 (1) ◽  
pp. 74-75
Author(s):  
N.D. Veen ◽  
J.P. Selten ◽  
H.W. Hoek ◽  
W.G. Feller ◽  
R.S. Kahn

2007 ◽  
Vol 89 (1-3) ◽  
pp. 86-90 ◽  
Author(s):  
K. Dean ◽  
P. Dazzan ◽  
T. Lloyd ◽  
C. Morgan ◽  
K. Morgan ◽  
...  

2008 ◽  
Vol 192 (3) ◽  
pp. 185-190 ◽  
Author(s):  
Claudia Cooper ◽  
Craig Morgan ◽  
Majella Byrne ◽  
Paola Dazzan ◽  
Kevin Morgan ◽  
...  

BackgroundPeople from Black ethnic groups (African-Caribbean and Black African) are more prone to develop psychosis in Western countries. This excess might be explained by perceptions of disadvantage.AimsTo investigate whether the higher incidence of psychosis in Black people is mediated by perceptions of disadvantage.MethodA population-based incidence and case-control study of first-episode psychosis (Aetiology and Ethnicity in Schizophrenia and Other Psychoses (ÆSOP)). A total of 482 participants answered questions about perceived disadvantage.ResultsBlack ethnic groups had a higher incidence of psychosis (OR=4.7, 95% CI 3.1–7.2). After controlling for religious affiliation, social class and unemployment, the association of ethnicity with psychosis was attenuated (OR=3.0, 95% CI 1.6–5.4) by perceptions of disadvantage. Participants in the Black non-psychosis group often attributed their disadvantage to racism, whereas Black people in the psychosis group attributed it to their own situation.ConclusionsPerceived disadvantage is partly associated with the excess of psychosis among Black people living in the UK. This may have implications for primary prevention.


Sign in / Sign up

Export Citation Format

Share Document